New research helps us to identify areas of opportunity to address in our lifestyle and diet.
High blood cholesterol numbers and the recurrence of prostate cancers is just one of such findings that has recently been in the news that we highlight in this newsletter.
Lifestyle changes and cholesterol treatment may be just one of the changes to embrace to remain healthy longer, even if you have been treated for prostate cancer.
Ilse Marie Issels
Wife and Collaborator of Dr. Josef Issels, Our Founder
Are you concerned about cholesterol and triglycerides creating problems for something other than your arteries? You should be. A recent study suggests a link between high blood fats and the recurrence of prostate cancer.
The significance of normal blood fat levels
In a study of 843 men whose prostates had been removed an association between high levels of cholesterol and triglycerides, so-called “bad cholesterol,” and an increased risk of prostate cancer recurrence was revealed.
Those with high cholesterol saw a 9 percent increase for every a10 mg/dL increase in cholesterol above 200 mg/dL. Thirty-five percent of those with a triglyceride level of 150 mg/dL or higher experienced recurrence as well. Read more information from the study.
Normalization of blood fats may reduce risk
Lead researchers at Duke University explained normalization – even partial – with the help of statins or dietary changes, suggests a link to a reduced risk of recurrence.
Increases in HDL, "good cholesterol", raise the bar
The Duke team also found increases in HDL or "good cholesterol" reduced the risk of recurrence in some men by 39 percent for every 10 milligrams per deciliter (mg/dL) increase in the blood.
A word of caution
Though a link was shown, this does not indicate high blood fat was a cause for cancer. Statins for protection are not recommended at this time, according to Dr. Anthony D'Amico, chief of radiation oncology at Brigham and Women's Hospital in Boston.
Understanding the role of blood fats is however important
Heart disease and cancer are the leading causes of death, attributable to 45 percent of fatalities worldwide. Further research is warranted to explore this modifiable risk factor and how to best effect it in order to save lives.
We invite you to contact one of our patient care specialists today to chat about how the Issels® Immuno-Oncology Program for Cancer may be the right choice for your health needs. We invite you to phone 1-888-447-7357 or visit us online at www.Issels.com.